You are here

  • Home
  • Archive
  • Volume 80, Issue 6
  • Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Article metrics

Article menu
XML
Rheumatoid arthritis
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

 

Online download statistics by month:

Online download statistics by month: January 2021 to October 2023

AbstractFullPdf
Jan 202113561329808
Feb 2021747729360
Mar 2021485475258
Apr 2021427417215
May 2021917906323
Jun 2021639627281
Jul 2021378368144
Aug 2021277273162
Sep 2021270264118
Oct 2021316303102
Nov 2021389383191
Dec 2021222218113
Jan 2022267266123
Feb 2022234222117
Mar 2022307310165
Apr 2022229227102
May 2022212211101
Jun 2022213216109
Jul 202218717681
Aug 2022161160103
Sep 2022192170107
Oct 202217516377
Nov 202215614676
Dec 202213412459
Jan 202317516484
Feb 202316315366
Mar 202316114991
Apr 202318716986
May 202317716881
Jun 202315614250
Jul 202315614366
Aug 2023113108105
Sep 202318117183
Oct 202322721562
Total10586102655069